Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Charles J Woodrow

Showing results (1-10 of 64) with videos related to

Pageof 7
Sort By:
Plos Clinical Trials|March 21, 2007
Phase III trial of albumin in malaria still lacks scientific justificationCharles J Woodrow, Timothy Planche
The Journal of Infectious Diseases|September 22, 2017
Pfhrp2 Deletions in the Democratic Republic of Congo: Evidence of Absence, or Absence of Evidence?Charles J Woodrow, Caterina Fanello
Plos Clinical Trials|February 10, 2007
Inadequate evidence to support phase III studies of albumin in severe malariaCharles J Woodrow, Timothy Planche
The New England Journal of Medicine|July 31, 2014
Parasite burden and severity of malaria in Tanzanian childrenCharles J Woodrow, Arjen M Dondorp
Antimicrobial Agents and Chemotherapy|April 21, 2010
Plasmodium falciparum ATP6 not under selection during introduction of artemisinin combination therapy in PeruCharles J Woodrow, Leyla Y Bustamante
FEMS Microbiology Reviews|September 11, 2016
The clinical impact of artemisinin resistance in Southeast Asia and the potential for future spreadCharles J Woodrow, Nicholas J White
Trends in Parasitology|December 1, 2010
Mechanisms of artemisinin action and resistance: wider focus is neededCharles J Woodrow, Leyla Y Bustamante
Lancet (London, England)|January 18, 2006
Artesunate versus quinine for severe falciparum malariaCharles J Woodrow, Timothy Planche, Sanjeev Krishna
The Journal of Infectious Diseases|June 27, 2012
Reappraisal of the efficacy of a simplified artesunate regimen in falciparum malariaCharles J Woodrow, Walter R J Taylor
BMJ Case Reports|January 16, 2020
Delayed diagnosis of T3 supplementation in a bodybuilder presenting with tachycardia and features of sepsisBronwen E Warner, Charles J Woodrow, Aparna Pal
Pageof 7

Showing results (1-10 of 64) with videos related to

Sort By:
Pageof 7
Plos Clinical Trials|March 21, 2007
Phase III trial of albumin in malaria still lacks scientific justificationCharles J Woodrow, Timothy Planche
The Journal of Infectious Diseases|September 22, 2017
Pfhrp2 Deletions in the Democratic Republic of Congo: Evidence of Absence, or Absence of Evidence?Charles J Woodrow, Caterina Fanello
Plos Clinical Trials|February 10, 2007
Inadequate evidence to support phase III studies of albumin in severe malariaCharles J Woodrow, Timothy Planche
The New England Journal of Medicine|July 31, 2014
Parasite burden and severity of malaria in Tanzanian childrenCharles J Woodrow, Arjen M Dondorp
Antimicrobial Agents and Chemotherapy|April 21, 2010
Plasmodium falciparum ATP6 not under selection during introduction of artemisinin combination therapy in PeruCharles J Woodrow, Leyla Y Bustamante
FEMS Microbiology Reviews|September 11, 2016
The clinical impact of artemisinin resistance in Southeast Asia and the potential for future spreadCharles J Woodrow, Nicholas J White
Trends in Parasitology|December 1, 2010
Mechanisms of artemisinin action and resistance: wider focus is neededCharles J Woodrow, Leyla Y Bustamante
Lancet (London, England)|January 18, 2006
Artesunate versus quinine for severe falciparum malariaCharles J Woodrow, Timothy Planche, Sanjeev Krishna
The Journal of Infectious Diseases|June 27, 2012
Reappraisal of the efficacy of a simplified artesunate regimen in falciparum malariaCharles J Woodrow, Walter R J Taylor
BMJ Case Reports|January 16, 2020
Delayed diagnosis of T3 supplementation in a bodybuilder presenting with tachycardia and features of sepsisBronwen E Warner, Charles J Woodrow, Aparna Pal
Pageof 7